Daily Banking News
$42.39
-0.38%
$164.24
-0.07%
$60.78
+0.07%
$32.38
+1.31%
$260.02
+0.21%
$372.02
+0.18%
$78.71
-0.06%
$103.99
-0.51%
$76.53
+1.19%
$2.81
-0.71%
$20.46
+0.34%
$72.10
+0.28%
$67.30
+0.42%

MGC Pharmaceuticals says ‘next step is to convert our efforts in research into


‘s () () () (FRA:H5O) Roby Zomer talks to Proactive’s Katie Pilbeam about the completed delivery of their first bulk order in March of ArtemiCTM Rescue to Swiss AG.

He says the ‘next step is to convert efforts in research into commercial revenue and take our company towards profitability…. now we’re ready’.

The deal equates to around $425,000 (€275,000) in wholesale production revenue to the company. Zomer sales it’s time to move all of this development into sales and build a sales team globally.



Read More: MGC Pharmaceuticals says ‘next step is to convert our efforts in research into

Get real time updates directly on you device, subscribe now.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.